At 9.6% CAGR, the South & Central America Poultry Diagnostic Market is Projected to be Worth US$ 105.35 million by 2030, Says Business Market Insights

According to Business Market Insights research, the South & Central America poultry diagnostic market was valued at US$ 50.52 million in 2022 and is expected to reach US$ 105.35 million by 2030, registering a CAGR of 9.6% from 2022 to 2030. Rising zoonotic disease cases and technological advancements attributed to the South & Central America poultry diagnostic market expansion. 

A report by Frontiers S.A. reveals that coccidiosis, salmonellosis, and Newcastle disease are the most common poultry diseases that prove dangerous for humans if not detected early. Smart technologies such as deep learning techniques are being explored for their potential in early poultry disease diagnoses. Deep learning technologies have been demonstrated to automate disease diagnostics procedures for humans and livestock, allowing poultry farmers to improve livestock health and boost yield. "Support Vector Machine (SVM)" is a learning method that has been in use for the efficient diagnosis of avian pox diseases in poultry and detection of hock burn prevalence in broiler chickens. Polymerase chain reaction (PCR) is a molecular biology technique for rapid diagnostics. It efficiently detects and identifies pathogens through amplification processes, ultimately saving time by shortening the testing process to several hours compared to traditional methods of culturing the disease-causing agents, which may take over a week for diagnosis.

AeroCollect, a Danish technology developed by FORCE Technology in collaboration with the Danpo Group, is a single air sample test that can facilitate early-stage disease detection among an entire flock of poultry. The product can safeguard poultry farmers from high operation losses, monitor vaccination efficiency more closely, and protect poultry from different infections, ultimately providing consumers with food safety. Thus, such technological advancements in poultry diagnostics are expected to provide prosperous opportunity to the market growth.

On the contrary, insufficient welfare measures for poultry hampers the South & Central America poultry diagnostic market.

Based on test type, the South & Central America poultry diagnostic market is segmented into enzyme-linked immunosorbent assay (ELISA) tests, polymerase chain reaction (PCR) tests, hemagglutination-inhibition (HI), and others. The enzyme-linked immunosorbent assay (ELISA) tests segment held 43.8% share of South & Central America poultry diagnostic market in 2022, amassing US$ 22.15 million. It is projected to garner US$ 48.15 million by 2030 to expand at 10.2% CAGR during 2022–2030.

In terms of disease, the South & Central America poultry diagnostic market is segmented into avian influenza, infectious bronchitis, avian salmonellosis, Newcastle disease, avian mycoplasmosis, and others. The avian mycoplasmosis segment held 30.1% share of South & Central America poultry diagnostic market in 2022, amassing US$ 15.19 million. It is projected to garner US$ 31.81 million by 2030 to expand at 9.7% CAGR during 2022–2030.

By country, the South & Central America poultry diagnostic market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 70.3% share of South & Central America poultry diagnostic market in 2022. It was assessed at US$ 35.53 million in 2022 and is likely to hit US$ 75.39 million by 2030, exhibiting a CAGR of 9.9% during 2022–2030. 

Key players operating the South & Central America poultry diagnostic market are Thermo Fisher Scientific Inc , Idexx Laboratories Inc , Qiagen NV , Eurofins Scientific SE , Boehringer Ingelheim International GmbH , Zoetis Inc , and BioCheck BV, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com